Hexagon Nutrition Share News - Latest Updates, Live News & More

Latest news about Hexagon Nutrition

Hexagon Nutrition FY26 PAT surges 56% to ₹379 million; AGM on Sep 22 Sep 01, 2026

Consolidated PAT surged 56% YoY to ₹379.37 million in FY26, outpacing 17.8% revenue growth. EBITDA margin expanded by 150 bps to 13.8%, reflecting improved operational efficiency. Branded nutrition segment crossed ₹1,000 million mark with 23.74% YoY growth. Company scheduled 33rd AGM for September 22, 2026, recommending ₹0.30 per share final dividend. Web-links for Integrated Annual Report distributed to members without registered emails.

Hexagon Nutrition faces ₹1.04 Cr customs duty demand and penalty Sep 01, 2026

Hexagon Nutrition MD Vikram Kelkar buys 16,300 shares in open market Aug 19, 2026

Hexagon Nutrition promoter Nikhil Kelkar acquires 16,400 shares Aug 19, 2026

Hexagon Nutrition Q1FY27 profit rises 25%; guides 20-25% growth Aug 18, 2026

More news about Hexagon Nutrition

17Aug 26

Hexagon Nutrition to host investor meetings on August 20

Hexagon Nutrition Limited announced physical investor meetings with Skyridge Fund Managers and Seven Island PMS on August 20, 2026. The sessions, held at the Andheri office, are strictly non-UPSII disclosures under SEBI Listing Regulations.

22Jul 26

Hexagon Nutrition reports FY26 PAT growth of 56.1%

Hexagon Nutrition reported a 17.8% year-on-year increase in revenue to ₹382.63 crore for FY26, with PAT growing 56.1% to ₹37.94 crore. EBITDA rose 32.01% to ₹52.90 crore, expanding margins to 13.83%. The company cited operational efficiency and a better product mix as key drivers. Branded segment margins were reported between 60-68%, while capacity utilization is expected to improve to 35-40%.

07Jul 26

Hexagon Nutrition directors resign after share divestment

Hexagon Nutrition Ltd accepted the resignations of Executive Director Subhash Purushottam Kelkar and Non-Executive Director Aditya Kelkar from its board effective July 6, 2026, following the complete divestment of their shareholding in the company. Both individuals were selling shareholders in the recently concluded initial public offering (IPO) and have fully exited the company. The company disclosed the changes in a regulatory filing submitted to BSE Limited and National Stock Exchange of India Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Hexagon Nutrition

67.99

-0.18

(-0.26%)

1 Year Returns:0.00%

Get More Market Insights with

Stock Rental via SLBM

About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

Part of Raise Financial Services

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357 Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104